
Anita M King
Examiner (ID: 15142)
Most Active Art Unit | 3632 |
Art Unit(s) | 3505, 2899, 3632 |
Total Applications | 2681 |
Issued Applications | 2122 |
Pending Applications | 127 |
Abandoned Applications | 408 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14227351
[patent_doc_number] => 20190125848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => DENDRITIC CELL-EXTRACELLULAR VESICLE FUSIONS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/088977
[patent_app_country] => US
[patent_app_date] => 2016-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088977 | DENDRITIC CELL-EXTRACELLULAR VESICLE FUSIONS AND METHODS OF USING SAME | Mar 29, 2016 | Abandoned |
Array
(
[id] => 11009765
[patent_doc_number] => 20160206718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'Compositions for Liquidation of Tumors'
[patent_app_type] => utility
[patent_app_number] => 15/084206
[patent_app_country] => US
[patent_app_date] => 2016-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6801
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15084206
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/084206 | Compositions for Liquidation of Tumors | Mar 28, 2016 | Pending |
Array
(
[id] => 11075748
[patent_doc_number] => 20160272713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'Fibrosis Inhibiting Compounds and Methods of Use Thereof in the Prevention or Treatment of Fibrosing Diseases'
[patent_app_type] => utility
[patent_app_number] => 15/083989
[patent_app_country] => US
[patent_app_date] => 2016-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8707
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15083989
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/083989 | Fibrosis Inhibiting Compounds and Methods of Use Thereof in the Prevention or Treatment of Fibrosing Diseases | Mar 28, 2016 | Abandoned |
Array
(
[id] => 12259431
[patent_doc_number] => 20180078627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'METHOD FOR ANTIGEN LOADING OF DENDRITIC CELLS AND VACCINE'
[patent_app_type] => utility
[patent_app_number] => 15/563542
[patent_app_country] => US
[patent_app_date] => 2016-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12814
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563542
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/563542 | METHOD FOR ANTIGEN LOADING OF DENDRITIC CELLS AND VACCINE | Mar 27, 2016 | Abandoned |
Array
(
[id] => 11085397
[patent_doc_number] => 20160282363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'Methods of Treating Subjects having Severe and/or Persistent Asthma'
[patent_app_type] => utility
[patent_app_number] => 15/080972
[patent_app_country] => US
[patent_app_date] => 2016-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 28694
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15080972
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/080972 | Methods of Treating Subjects having Severe and/or Persistent Asthma | Mar 24, 2016 | Abandoned |
Array
(
[id] => 11393915
[patent_doc_number] => 20170014451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'COMPOSITIONS AND METHODS OF TREATING T CELL MEDIATED DISORDER'
[patent_app_type] => utility
[patent_app_number] => 15/077256
[patent_app_country] => US
[patent_app_date] => 2016-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15076
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15077256
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/077256 | Compositions and methods of treating T cell mediated disorder | Mar 21, 2016 | Issued |
Array
(
[id] => 12233366
[patent_doc_number] => 20180066229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'METHOD FOR PREPARING DENDRITIC CELLS VIA NON-ADHESIVE CULTURE USING IFN'
[patent_app_type] => utility
[patent_app_number] => 15/558755
[patent_app_country] => US
[patent_app_date] => 2016-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 9775
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558755
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/558755 | METHOD FOR PREPARING DENDRITIC CELLS VIA NON-ADHESIVE CULTURE USING IFN | Mar 15, 2016 | Abandoned |
Array
(
[id] => 11047564
[patent_doc_number] => 20160244521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'ANTI-PVRIG ANTIBODIES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/048967
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 211
[patent_figures_cnt] => 211
[patent_no_of_words] => 74736
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15048967
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/048967 | Anti-PVRIG antibodies and methods of use | Feb 18, 2016 | Issued |
Array
(
[id] => 11075745
[patent_doc_number] => 20160272709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'ANTI-KIR ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/043071
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17425
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15043071
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/043071 | ANTI-KIR ANTIBODIES | Feb 11, 2016 | Abandoned |
Array
(
[id] => 11002574
[patent_doc_number] => 20160199523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'SOLUBLE TCR MOLECULES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/040724
[patent_app_country] => US
[patent_app_date] => 2016-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 20313
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15040724
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/040724 | SOLUBLE TCR MOLECULES AND METHODS OF USE | Feb 9, 2016 | Abandoned |
Array
(
[id] => 11074273
[patent_doc_number] => 20160271237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/019857
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 29920
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019857
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019857 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS | Feb 8, 2016 | Abandoned |
Array
(
[id] => 10979994
[patent_doc_number] => 20160176938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'Partial Region Polypeptide of REIC/Dkk-3 Protein'
[patent_app_type] => utility
[patent_app_number] => 14/997186
[patent_app_country] => US
[patent_app_date] => 2016-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 19137
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14997186
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/997186 | Partial region polypeptide of REIC/Dkk-3 protein | Jan 14, 2016 | Issued |
Array
(
[id] => 10761950
[patent_doc_number] => 20160108103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'IMMUNOGENIC PEPTIDES AND THEIR USE IN TRANSPLANTATION'
[patent_app_type] => utility
[patent_app_number] => 14/980932
[patent_app_country] => US
[patent_app_date] => 2015-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16888
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14980932
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/980932 | IMMUNOGENIC PEPTIDES AND THEIR USE IN TRANSPLANTATION | Dec 27, 2015 | Abandoned |
Array
(
[id] => 13714291
[patent_doc_number] => 20170368100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => METHOD FOR THE IDENTIFICATION OF TRANSIENTLY FOXP3 NEGATIVE REGULATORY T-CELLS FROM HUMAN PERIPHERAL BLOOD
[patent_app_type] => utility
[patent_app_number] => 15/539313
[patent_app_country] => US
[patent_app_date] => 2015-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539313
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539313 | METHOD FOR THE IDENTIFICATION OF TRANSIENTLY FOXP3 NEGATIVE REGULATORY T-CELLS FROM HUMAN PERIPHERAL BLOOD | Dec 22, 2015 | Abandoned |
Array
(
[id] => 13856383
[patent_doc_number] => 10189902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Antibodies to TIGIT
[patent_app_type] => utility
[patent_app_number] => 14/977789
[patent_app_country] => US
[patent_app_date] => 2015-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 48847
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14977789
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/977789 | Antibodies to TIGIT | Dec 21, 2015 | Issued |
Array
(
[id] => 10784187
[patent_doc_number] => 20160130343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'ANTI-ILT7 ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 14/971303
[patent_app_country] => US
[patent_app_date] => 2015-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 25137
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14971303
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/971303 | ANTI-ILT7 ANTIBODY | Dec 15, 2015 | Abandoned |
Array
(
[id] => 11304811
[patent_doc_number] => 09512197
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'High affinity NY-ESO T cell receptors'
[patent_app_type] => utility
[patent_app_number] => 14/967584
[patent_app_country] => US
[patent_app_date] => 2015-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 50
[patent_no_of_words] => 13614
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14967584
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/967584 | High affinity NY-ESO T cell receptors | Dec 13, 2015 | Issued |
Array
(
[id] => 10805314
[patent_doc_number] => 20160151471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'INDUCIBLE REGULATORY T-CELL GENERATION FOR HEMATOPOIETIC TRANSPLANTS'
[patent_app_type] => utility
[patent_app_number] => 14/965432
[patent_app_country] => US
[patent_app_date] => 2015-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19731
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14965432
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/965432 | INDUCIBLE REGULATORY T-CELL GENERATION FOR HEMATOPOIETIC TRANSPLANTS | Dec 9, 2015 | Abandoned |
Array
(
[id] => 10823703
[patent_doc_number] => 20160169869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'SYSTEMS AND METHODS FOR ASSESSING MODULATORS OF IMMUNE CHECKPOINTS'
[patent_app_type] => utility
[patent_app_number] => 14/947660
[patent_app_country] => US
[patent_app_date] => 2015-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 18028
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14947660
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/947660 | SYSTEMS AND METHODS FOR ASSESSING MODULATORS OF IMMUNE CHECKPOINTS | Nov 19, 2015 | Abandoned |
Array
(
[id] => 10791590
[patent_doc_number] => 20160137747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'Antibodies Against Human CD39 and Use Thereof for Inhibiting T Regulatory Cells Activity'
[patent_app_type] => utility
[patent_app_number] => 14/939650
[patent_app_country] => US
[patent_app_date] => 2015-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11318
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14939650
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/939650 | Antibodies against human CD39 and use thereof for inhibiting T regulatory cells activity | Nov 11, 2015 | Issued |